1. Home
  2. GP vs NLSP Comparison

GP vs NLSP Comparison

Compare GP & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GP
  • NLSP
  • Stock Information
  • Founded
  • GP 2010
  • NLSP 2015
  • Country
  • GP Canada
  • NLSP Switzerland
  • Employees
  • GP N/A
  • NLSP N/A
  • Industry
  • GP Construction/Ag Equipment/Trucks
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • GP Consumer Discretionary
  • NLSP Health Care
  • Exchange
  • GP Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • GP 10.5M
  • NLSP 12.4M
  • IPO Year
  • GP 2020
  • NLSP 2021
  • Fundamental
  • Price
  • GP $3.96
  • NLSP $2.03
  • Analyst Decision
  • GP Strong Buy
  • NLSP
  • Analyst Count
  • GP 1
  • NLSP 0
  • Target Price
  • GP $30.00
  • NLSP N/A
  • AVG Volume (30 Days)
  • GP 261.5K
  • NLSP 193.3K
  • Earning Date
  • GP 11-13-2025
  • NLSP 10-17-2025
  • Dividend Yield
  • GP N/A
  • NLSP N/A
  • EPS Growth
  • GP N/A
  • NLSP N/A
  • EPS
  • GP N/A
  • NLSP N/A
  • Revenue
  • GP $18,399,688.00
  • NLSP N/A
  • Revenue This Year
  • GP $81.12
  • NLSP N/A
  • Revenue Next Year
  • GP $91.69
  • NLSP N/A
  • P/E Ratio
  • GP N/A
  • NLSP N/A
  • Revenue Growth
  • GP N/A
  • NLSP N/A
  • 52 Week Low
  • GP $2.28
  • NLSP $1.30
  • 52 Week High
  • GP $18.50
  • NLSP $6.97
  • Technical
  • Relative Strength Index (RSI)
  • GP 57.05
  • NLSP 43.44
  • Support Level
  • GP $3.09
  • NLSP $1.88
  • Resistance Level
  • GP $3.66
  • NLSP $2.29
  • Average True Range (ATR)
  • GP 0.45
  • NLSP 0.12
  • MACD
  • GP 0.09
  • NLSP -0.01
  • Stochastic Oscillator
  • GP 99.51
  • NLSP 36.59

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: